SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?


To: Anthony Wong who wrote (2320)7/22/1999 3:49:00 PM
From: Dan Spillane  Read Replies (1) | Respond to of 2539
 
CBS misrepresentation?

As far as I know, there was already one unfair mis-representation, in the first CBS broadcast.

I don't believe the scientist they quote (Fagan) "tests food" for SAFETY. Rather, he tests food for the presence of specific genes, once the European public is made scared enough of some product -- and I think he runs a lab which CHARGES for this service. So...then he BENEFITS from scaring people. Therefore, it seems unethical for CBS not to point this out, since his comments might scare some people:

(from the CBS story)
John Fagan, an American scientist whose laboratory tests genetic foods for European companies also believes GM foods need more research. "In fact every time you put in a gene it's causing genetic mutations to the existing genes of that organism, and so there are unexpected side effects that can come out of this process."

***

Anyone else agree?

cbs.com



To: Anthony Wong who wrote (2320)7/22/1999 9:40:00 PM
From: Dan Spillane  Respond to of 2539
 
Dutch court freezes Greenpeace bank account
Copyright © 1999 Nando Media
Copyright © 1999 Reuters News Service
By SIMON GARDNER

LONDON (July 21, 1999 3:13 p.m. EDT nandotimes.com) - A Dutch court has frozen the bank account of environmental group Greenpeace International after a nuclear protest earlier this week, according to British Nuclear Fuels Ltd., which sought the court ruling.

British Nuclear Fuels said it had asked Amsterdam's Court of First Instance to block the group's funds so that it could reclaim compensation for costs incurred during Monday's demonstration, when Greenpeace delayed a shipment of nuclear fuel to Japan.

Dutch bank ABN Amro, where Greenpeace International has its bank account, declined comment.

"BNFL is not seeking to bankrupt Greenpeace ... however the company does need to be able to recover damages which may be awarded by the courts for the extra costs we have incurred through Greenpeace's illegal actions," the energy company said.

Greenpeace slammed the state-run firm's move as "financial terrorism," vowing to continue with its campaign to expose the plutonium industry.

"It is an obscene miscarriage of justice that Greenpeace is under attack rather than the French, British and Japanese governments, who are conducting a massive trade in weapons-usable plutonium," Greenpeace Director Bruno Rebelle said.

The group said the freeze on its ABN Amro account in Amsterdam, where Greenpeace International is based, took effect late Tuesday.

The court's move came just hours after the British government banned one of the group's protest ships from part of the route taken by the nuclear convoy when it eventually set sail Monday -- also at the behest of BNFL.

nandotimes.com ml



To: Anthony Wong who wrote (2320)7/22/1999 11:52:00 PM
From: Dan Spillane  Respond to of 2539
 
FIRST LINE PRESIDENT BACKS BIOTECH
August 1, 1999Eastern Ontario AgriNews
ST. ALBERT - Peter Hannam, president of Guelph's First Line Seeds, was
cited as saying at the opening of R.D. Legault Seeds' new processing
operation and warehouse here June 25 that he doesn't share Europeans'
concerns over food biotechnology, calling it a fear of the unknown, and
that as biotech's story is told, these suspicions will be allayed and
those who now oppose genetic alterations to crops like soybeans will
realize the benefits of these scientific developments.,
Hannam, a diabetic for 30 years, was cited as saying he developed a severe
allergy to insulin produced from pigs and is fortunate that biotech
managed to isolate a human gene that permitted the pharmaceutical industry
to produce pure human insulin.
And First Line wants to be at the head of the line when these developments
occur, he said.First Line has already forged an alliance with Monsanto, the St.
Louis-based food giant whose scientists have been on the cutting edge of
genetic re-engineering. Monsanto has purchased shares in First Line from
each of the company's 13 shareholders.
This has given First Line access to "the best technology" available,Hannam said.
Roundup Ready beans have been a resounding success story and he predicted
this is the just the edge of the wedge in crop developments as growers
strive to meet what he says will be a burgeoning of worldwide demand not
only for beans' chemical potential, but also for their protein
capabilities. This is particularly true in Asia, where 90 per cent of the
world's future population growth is expected and where the soybean is the
major source of protein First Line, under its Nutriline products, is one
of the few companies in North American - and the world - that is breeding
traits into soybeans for specific end markets. This is already happening
with the bean curd known as tofu, in which breeding lines are established
for different types of the product.



To: Anthony Wong who wrote (2320)7/22/1999 11:54:00 PM
From: Dan Spillane  Respond to of 2539
 
FUSARIUM RISK TO BARLEY IS REAL
July 22, 1999
Manitoba Co-operator Gord Gilmour
Brandon -- Fusarium head blight could, according to this story, curtail
barley production on the Canadian Prairies, unless consumer acceptance of
genetically modified crops becomes more widespread.
Mario Therrien, program leader for barley breeding and physiology at the
Brandon Research Centre, was cited as telling producers last week at the
centre's annual open house resistance derived through biotechnology is the
only avenue left for breeders, adding, "Basically we did the route of
traditional breeding and failed. We're now working on GMO resistance and
we will succeed there. What does remain to be seen is if it will be
accepted. People will seem to accept GMOs for medical purposes, but they
don't want them in their beer. ... It has enough protection now that in
the case of background infections it can ward them off well enough that
there won't be major yield losses or quality concerns."
Hulless varieties offer some intermediate protection because the hull
comes off and the seed is protected by it.
At the bottom of the pile are the six-row varieties with virtually noresistance.



To: Anthony Wong who wrote (2320)7/23/1999 12:30:00 AM
From: Dan Spillane  Respond to of 2539
 
Genetically Modified Crops Already Diminishing Undernutrition

Professor Michael Lipton
University of Sussex
12 July 1999

Genetically Modified Crops Already Diminishing Undernutrition

Sir, Dr Alok Bhargava (Financial Times, Letters, June 14) alleged that my "argument that (genetically) modified foods will reduce undernutrition is . . . premature". But GM staple foods are doing so already. The gains would be greater if they received more than the present 5-10 per cent of GM research. The Nuffield report on GM crops documents varieties that have improved yield and stability - often by better tolerance of fungi, viruses or soil poisons - for example, for rice in China, potatoes in Peru and sweet potatoes in Kenya.

Yes, GM foods need long-term health monitoring, though they have been grown commercially in the US since 1994, and on well over 1m hectares in China, with no reported health damage. The Nuffield report suggests that new aid should help developing countries to design and implement appropriate, open procedures to regulate, improve and monitor the health and environmental impact of specific GM varieties. However, as the World Health Organisation and the UN Food and Agriculture Organisation agree, a huge source of health damage is undernutrition and underemployment due to risky and unproductive varieties of staple food crops. Hence caution demands not only regulation and monitoring but also a big increase in the present dismally low share of GM research that tests or spreads improved varieties of food staples.

Finally, Dr Bhargava stated that my arguing for GM foods as a weapon against undernutrition "would even seem disingenuous to those who see it as a conspiracy to experiment with dangerous products on the most vulnerable". "Those who see it" that way are making groundless charges of disingenuousness and callousness. I see no ethical grounds for denying Vitamin A-enhanced GM rice to children at risk of eye damage but I accept the good faith of those who do. "Those who" unreasonably attack others' good faith, especially if also failing to address the substance of a controversy, merely demonstrate the weakness of their own case.

--------------------------------------------------------------------------------
Michael Lipton,
professor of economics,
Poverty Research Unit,
Sussex University,
and member, working party on GM crops,
Nuffield Council on Bioethics,
Falmer, Brighton, Sussex BN1 9SJ




To: Anthony Wong who wrote (2320)7/23/1999 2:05:00 AM
From: Dan Spillane  Respond to of 2539
 
[Notice the second story, exactly as I have been saying.]
Friday July 23, 1:39 am Eastern Time
PRESS DIGEST - Washington Post business - July 23
WASHINGTON, July 22 (Reuters) - The Washington Post included the following stories on the front page of its business section on July 23:

---

BERLIN - European Union's raid on offices of Coca-Cola Co in four countries represents the latest attack on U.S. corporate giants that have seized opportunity spawned by a single European market to expand reach across continent.

washingtonpost.com



To: Anthony Wong who wrote (2320)7/24/1999 3:11:00 PM
From: Dan Spillane  Read Replies (2) | Respond to of 2539
 
NYTimes July 20, 1999 Stalked by Deadly Virus, Papaya Lives to Breed Again

By CAROL KAESUK YOON
n the island of Hawaii, on what had been acres of withering, disease-infested plants, farmers this summer are walking among rows of lush green trees, harvesting the world's first crop of genetically engineered papayas.

Steve Ferreira

Healthy genetically altered papaya plants thrived on the right in 1996 as the traditional plants, at left, withered.
--------------------------------------------------------------------------------

Designed with a gene that allows them to withstand the papaya ringspot virus -- an incurable disease that ruins fruit and can sicken trees to the point of killing them -- these genetically modified plants are already being credited with saving an industry that was on its way out.

In the past seven years as the virus wiped out farm after farm in Hawaii's major papaya growing region, farmers continually sought out new land in what became increasingly futile attempts to escape the spreading disease. Some farmers grew so desperate that they broke into experimental fields and stole genetically engineered papaya seeds before they were approved for use by the Department of Agriculture.

"This industry was dying," said Emerson Llantero, manager of the Papaya Administrative Committee, a research and marketing group supported by papaya farms, most of which are small, family operations of 10 to 20 acres. The new papaya, he said, is a second chance for growers.

In an expanding debate over potential problems with genetically engineered crops, including corn pollen that can kill monarch butterflies and Europe's reluctance to accept genetically engineered foods, some have argued that these novel plants have provided relatively minor tangible benefits.

But farmers like Orlando Manuel, who has abandoned several farms in an effort to escape the virus, would argue otherwise for the new papaya. He said this year that he planted his entire 20 acres in the genetically modified plant known as Rainbow.

"I'd be out of business without it," Mr. Manuel said. "There's nowhere to go. You can run but you cannot hide."

The first of the Rainbow papayas are on sale in grocery stores in Hawaii and on the mainland. Like other genetically modified crops, they have drawn little reaction from the American public. Still, the new papaya is not without controversy or risks.

Organic farmers say they are concerned about ecological risks.

Researchers inserted the disease virus's DNA into the plant's DNA, using a method that had succeeded in protecting other crops, though the exact mechanism of how this works is still being investigated. The risks include the creation of new and more potent viral diseases. Growers also worry that the Rainbow plants may contaminate nearby organic papaya plants by fertilizing them with genetically modified pollen.

--------------------------------------------------------------------------------

For better or worse, genetic engineering comes to the rescue of Hawaiian farmers.

--------------------------------------------------------------------------------

"There's been alarm here in the local area," said Roy Smith, president of Hawaii Organic Farmers Association. Mr. Smith said he had been receiving calls from farmers and consumers.

At the same time, the international backlash against genetically modified crops has begun to hit papayas. Dr. Dennis Gonsalves, plant pathologist at Cornell University and one of the creators of the new papaya, said the Mexican Government requested that he destroy experimental fields of genetically modified papaya in Mexico because of growing concerns over possible environmental risks, risks that he says do not exist.

But acknowledging that there could be other risks from genetically modified papaya, Dr. Gonsalves said even these were minimal compared with the benefits.

"People use infinitesimal calculations that this thing might happen and this thing might happen," Dr. Gonsalves said. "If everybody thinks that everything's got to be perfect with genetically engineered stuff, then you can forget about it. We can let the papaya industry die."

Hawaii's farmers have planted about 1,000 acres in Rainbow, one-third of the papaya acreage in the state. Mr. Llantero said farmers were planting the new seeds as fast as they became available.

But despite the risk from the papaya ringspot virus, not everyone is ready to plant Rainbow. Industry watchers say some growers wonder whether there is a sufficient market for genetically modified papayas. Typically 35 percent to 40 percent of the Hawaiian harvest is sold to Japan, where genetically modified papayas have not been approved for sale.

The disease first appeared on the Hawaiian island of Oahu in the 1940's, and slowly spread from farm to farm and island to island. Seven years ago, the virus made its way to the island of Hawaii, where nearly all the state's papayas are grown. Biologists say none of their attempts to cure or prevent the disease -- including traditional plant breeding, removal of diseased trees and a type of plant vaccination -- were effective. (Though called trees, papaya plants are actually extremely large herbs.)

It was Dr. Gonsalves, with colleagues at the University of Hawaii and the Agriculture Department, who began efforts to create a virus-resistant papaya.

Test plots grown in infected areas of Hawaii made clear the genetically modified, or transgenic, plant's ability to resist the virus. Transgenic plants grew healthy and green, side by side with traditional varieties that yellowed, withered and died.

University of Hawaii

The developers of a papaya that is resistant to a deadly virus, from left, are Maureen Fitch, a Hawaii graduate student, Dr. Dennis Gonsalves and Dr. Richard Manshardt.
--------------------------------------------------------------------------------

But at the same time that Rainbow has solved a problem for some farmers, it may be creating problems for others. Dr. Gonsalves said that organic papaya plants growing near genetically modified papaya could be fertilized by genetically engineered pollen. The fruits produced would then carry seeds with the engineered virus gene. If these seeds are replanted by organic farmers, then they will unknowingly be growing genetically modified fruits, which are by definition, not organic.

"Growers want to know, is there a cost-effective way to make sure that they're not planting genetically modified crops?" Mr. Smith said. "It's difficult to find an affordable path to that kind of integrity." He said Hawaiian farmers produced about $300,000 worth of organic papaya each year, compared with nonorganic papaya, which was worth about $18 million a year to farmers.

In addition, the plant may pose broader ecological risks. Dr. Peter Palukaitis, molecular virologist at the Scottish Crop Research Institute in Dundee, said there were a number of ways in which the new papaya could lead to the creation of new viruses, as is the case whenever a virus gene is inserted into a plant's DNA.

For example, researchers say the genetically engineered virus gene in Rainbow may end up mixing with DNA from other viruses that infect these papaya plants, possibly resulting in the creation of new, potentially more virulent disease-causing viruses. With scientists still working to understand such interactions, it remains unclear how readily new viruses may arise by these means. Other risks include synergy, a situation in which the mere presence of the genetically engineered virus in the plant's DNA makes it sicker than it would be otherwise when infected by another plant virus.

Rainbow does not have wild relatives in Hawaii, so it cannot spread its genetically engineered genes by creating hybrids with native plants.

In addition, Dr. Gonsalves said there appeared to be no risk to humans from eating the protein produced by the virus gene in the papaya. He said people had been eating infected fruits containing the viral protein for years with no ill effect.

Researchers say, despite its apparently iron-clad resistance, Rainbow is unlikely to protect Hawaii's farmers forever. A new virus might make its way to the islands, evolve on the islands, or already exist there in low numbers, and it could overcome the protection now offered by Rainbow.

"We'd all be nuts to say that this is the final solution," said Dr. Richard Manshardt, tropical fruit crops breeder and a creator of Rainbow, at the University of Hawaii. "Biological systems evolve."

Like all Rainbow growers, Mr. Manuel received his genetically modified seeds free from the Papaya Administrative Committee. Unlike nearly every other genetically modified crop that has been approved for commercial use, the new papaya was not produced by profit-motivated seed companies, but by researchers at Cornell University, the University of Hawaii and the Agriculture Department who have allowed growers to use it free of charge.

But Mr. Llantero said the Papaya Administrative Committee was looking into selling the seeds to recoup the costs of seed production, and Dr. Manshardt said the University of Hawaii was also beginning to look into ways of earning money for research from the fruit they helped to create.

Ultimately what will determine the success of the new papayas, which differ somewhat in taste and color from the traditional variety grown in Hawaii, is whether consumers are interested in eating them.

"Food is what you're brought up with,"said Stephanie Whalen, president and director of research at the Hawaii Agriculture Research Center. As for the market that the transgenic papaya can command, she added, "Only time will tell."